Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmaceutical Manufacturing And Innovation Projects Speed Up

This article was originally published in PharmAsia News

Executive Summary

According to the China Pharmaceutical Technology Transfer Center and the China Pharmaceutical Technology Organization, a Dec. 7 national advanced pharmaceutical technology management training class will focus on process management in the pharmaceutical manufacturing and innovation project (PharmAsia News, Sep. 8, 2008) under the country's 11th Five-Year Plan (2006-2010). At present, work on the first batch of project applications has been completed and the acceptance list will be publicized soon. A total of 3,290 proposed projects for the second batch are under appraisal and classes will begin next year. Subjects cover pivotal technology research in new drug development, establishment of technology platforms for drug innovation and construction of new drug incubation centers for enterprises. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067363

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel